Talkspace
TALKTalkspace is a publicly traded (NASDAQ: TALK) telehealth platform offering online therapy and psychiatry, notable among prescribers for declining to prescribe controlled substances.
What we like
What to watch
Full Review
Talkspace has operated since 2012 and became a public company via SPAC merger, giving it more financial and regulatory disclosure transparency than most peers in this category. Its psychiatry service treats over 150 conditions through a roughly 34-drug non-controlled formulary, avoiding stimulants, benzodiazepines, and other Schedule II-V medications entirely — a structural choice that removes the DEA telemedicine-flexibility risk facing competitors. Self-pay pricing runs $299 for an initial evaluation and $175 per quarterly follow-up, though most users appear to access the platform through insurance, with copays as low as $0. Trustpilot sentiment (4.4/5 across 2,388 reviews) is favorable overall, with recurring complaints centered on billing disputes and cancellation-fee enforcement rather than clinical quality.
Last researched: 2026-09-19
Pricing
Prices shown are based on our most recent research and may not reflect current pricing. Telehealth providers update their pricing frequently. Always verify pricing directly with the provider before purchasing.
| Treatment | Category | Price/mo | Includes | Notes |
|---|---|---|---|---|
| Psychiatric Evaluation & Prescription | Mental Health | $299 | ● Consults○ Lab work○ Shipping | No subscription needed |
| Psychiatry Follow-Up (Medication Management) | Mental Health | $175 | ● Consults○ Lab work○ Shipping | Subscription required |